FSSAI has filed three adjudication cases involving Nestlé India’s infant nutrition products, including claims around “5 HMOs,” whey protein and “easy to digest.” Separately, a follow-up formula sample failed prescribed biotin standards after referral testing. Nestlé says its products and labels comply with applicable requirements, keeping the focus on whether certain claims crossed India’s strict infant-food marketing rules.
